Drug Profile
Olomoucine
Alternative Names: NSC 666096Latest Information Update: 12 Jul 2007
Price :
$50
*
At a glance
- Originator Calbiochem
- Class Antineoplastics; Purines; Small molecules
- Mechanism of Action CDC2 protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 Aug 2002 No development reported - Preclinical for Cancer in France (unspecified route)
- 19 Aug 2002 No development reported - Preclinical for Cancer in United Kingdom (unspecified route)
- 12 Aug 2002 No development reported - Preclinical for Cancer in Czech Republic (unspecified route)